| 000 | 01375 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511200115.0 | ||
| 264 | 0 | _c19920626 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0304-3940 | ||
| 024 | 7 |
_a10.1016/0304-3940(91)90591-g _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJudge, M E | |
| 245 | 0 | 0 |
_aProtection against post-ischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil. _h[electronic resource] |
| 260 |
_bNeuroscience letters _cDec 1991 |
||
| 300 |
_a291-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aGerbillinae |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aPyramidal Tracts _xdrug effects |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 | _aReceptors, AMPA |
| 650 | 0 | 4 |
_aReceptors, Neurotransmitter _xantagonists & inhibitors |
| 700 | 1 | _aSheardown, M J | |
| 700 | 1 | _aJacobsen, P | |
| 700 | 1 | _aHonoré, T | |
| 773 | 0 |
_tNeuroscience letters _gvol. 133 _gno. 2 _gp. 291-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0304-3940(91)90591-g _zAvailable from publisher's website |
| 999 |
_c1674286 _d1674286 |
||